By comparing lipidomic profiles and PPARγ expression across these depots, our investigation provides a comprehensive understanding of how plasma FAs differentially modulate adipose tissue biology and contribute to obesity‐related metabolic risk. The gene discussed is PPARG; the disease is obesity disorder.